|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
New Jersey Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing New JerseyLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Emisphere Technologies Inc.
| | | Phone: | (973) 532-8000 | Fax: | (973) 532-8121 | Year Established: | 1986 | Ticker: | EMIS | Exchange: | OTCBB | Main Contact: | Alan L. Rubino, CEO | | Other Contacts: | David Gschneidner Ph.D., VP, Carrier R&D Carlos de Lecea, M.D., Global Head of Business Development Nicholas G. Rothwell, CPIM, VP, Global Supply Carl V. Sailer, VP, Sales & Marketing M. Gary I. Riley, DVM. Ph.D., DACVP.DABT, CSO
| | Company Description | Emisphere Technologies iis a biopharmaceutical company that focuses on a unique and improved delivery of pharmaceutical compounds, medical foods and dietary supplements using its Eligen® Technology. These molecules and compounds could be currently available or in development. Such molecules are usually delivered by injection; in many cases, their benefits are limited due to poor bioavailability, slow on-set of action or variable absorption. The Eligen® Technology can be applied to the oral route of administration as well other delivery pathways, such as buccal, rectal, inhalation, intra-vaginal or transdermal. | |
|
|
|
|
|